Luc-Sylvain Gilbert
Publications
Publications
|
|
Real access to ATMPs: the cost issueEuropean Society of Gene & Cell Therapy 2024, Oct 2024, Rome, Italy |
|
|
Expediting marketing authorization pathways for patients’ access to advanced therapiesEuropean Association of Health Law 2024, Sep 2024, Warsaw, Poland |
|
|
The Marketing Authorisation of Advanced Therapy Medicinal Products under the regulation of the European UnionInternational Society for Cell & Gene Therapy 2023 Annual Meeting, May 2023, Paris Palais des congrès, France. Abstract published in Cytotherapy, 25 (6 Supplement), pp.S160-S161, 2023 |
|
|
Illustrating regulatory requirements for the development of Gene and Cell therapy products with the EuroGCT research pathwaysEuropean Society for Blood and Marrow Transplant 49th annual meeting, Apr 2023, Paris, France |
|
|
The challenges of Advanced Therapy Medicinal Products manufacturing in the European Union: Strengths and limits of current regulatory toolsEuropean Society for Gene & Cell Therapy Congress 2023, Oct 2023, Bruxelles (BEL), Belgium |
|
|
Mapping regulators’ early interactions procedures to support innovationEuropean Society for Gene & Cell Therapy Congress 2023, Oct 2023, Bruxelles (BEL), Belgium |
|
|
Bringing gene and cell therapies from lab to patients: the EuroGCT research pathwaysEuropean Society for Gene & Cell Therapy Congress 2022, Oct 2022, Edinburgh, United Kingdom |
Principes fondamentaux de la protection des données2024 |
|
Utilisation abusive / détournée des données2024 |
|
Autorités de protection des données2024 |
|
Classification des données2024 |
The EuroGCT project and the potential involvement of EAHL membersMeeting of the EAHL Interest Group on Supranational Biolaw, Annual Conference of the European Association of Health Law, 20-22 April 2022, Apr 2022, Ghent, Belgium |